<!DOCTYPE html>
<html lang="en"><head>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-html/tabby.min.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/light-border.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting-0815c480559380816a4d1ea211a47e91.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.7.29">

  <title>talks – Chemotherapy and Sarcopenia</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="site_libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="site_libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
    /* CSS for citations */
    div.csl-bib-body { }
    div.csl-entry {
      clear: both;
      margin-bottom: 0em;
    }
    .hanging-indent div.csl-entry {
      margin-left:2em;
      text-indent:-2em;
    }
    div.csl-left-margin {
      min-width:2em;
      float:left;
    }
    div.csl-right-inline {
      margin-left:2em;
      padding-left:1em;
    }
    div.csl-indent {
      margin-left: 2em;
    }  </style>
  <link rel="stylesheet" href="site_libs/revealjs/dist/theme/quarto-f563837468303362081e247dddd440d0.css">
  <link href="site_libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="site_libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="site_libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="site_libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Chemotherapy and Sarcopenia</h1>

<div class="quarto-title-authors">
</div>

</section>
<section id="chemotherapy-and-elderly---adjuvant" class="title-slide slide level1 center">
<h1>Chemotherapy and Elderly - Adjuvant</h1>

</section>

<section>
<section id="chemotherapy-and-elderly---stage-iv" class="title-slide slide level1 center">
<h1>Chemotherapy and Elderly - Stage IV</h1>
<p>Colorectal cancer: 1013 patients with Stage IV CRC compared &lt;70 vs 70+. Older patients less likely to receive chemotherapy but among those that did receive chemo, improvement in survival was seen in both the older and younger groups <span class="citation" data-cites="chan147">(<a href="#/section" role="doc-biblioref" onclick="">Chan et al., 2017</a>)</span></p>
<p>Colorectal: Figer A, Perez-Staub N, Carola E, Tournigand C, Lledo G, Flesch M, Barcelo R, Cervantes A, André T, Colin P, et al.&nbsp;FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer. 2007;110:2666–2671.</p>
<p>For frail patients, either 5FU alone or stop and to strategy</p>
</section>
<h3 id="targeted-therapy-and-elderly">Targeted therapy and Elderly</h3></section>
<section id="frailty-and-chemotherapy" class="title-slide slide level1 center">
<h1>Frailty and Chemotherapy</h1>
<p>Chemotherapy in frail patients:</p>
<p>Choosing Wisely <span class="citation" data-cites="schnipper10">(<a href="#/section" role="doc-biblioref" onclick="">Schnipper et al., n.d.</a>)</span></p>
<p>ASCO statement <span class="citation" data-cites="hurria3826">(<a href="#/section" role="doc-biblioref" onclick="">Hurria et al., 2015</a>)</span></p>
<p>Cancer patients in the UK have worse survival likely due to undertreatment after age 65 - editorial <span class="citation" data-cites="chanda">(<a href="#/section" role="doc-biblioref" onclick=""><strong>chanda?</strong></a>)</span></p>
</section>

<section>
<section id="colorectal-cancer-in-elderly" class="title-slide slide level1 center">
<h1>Colorectal Cancer in Elderly</h1>
<p>Colorectal cancer. Estimated cases in US: 148,000 cases per year, of whom 80,000 are over age 65</p>
<p>NCDB of colon cancer: less adherence to treatment guidelines in elderly patients <span class="citation" data-cites="chen3395">(<a href="#/section" role="doc-biblioref" onclick="">Chen et al., 2020</a>)</span></p>
<p>Stage IV colon cancer over age 75: Equivalent response rates in patients older than 75 and younger. <span class="citation" data-cites="rosati578">(<a href="#/section" role="doc-biblioref" onclick="">Rosati et al., 2019</a>)</span></p>
<p>Meta-analysis of 13 trials of palliative chemotherapy in advanced colorectal cancer showed that chemotherapy for colorectal cancer improves survival by 3.7months and results in improvement of survival of 16% at both 6 and 12 months. ECOG 3/4 only comprise &lt;10% of the total sample of trial participants.<span class="citation" data-cites="simmonds531">(<a href="#/section" role="doc-biblioref" onclick="">Simmonds, 2000</a>)</span></p>
<p>PS2 patients with stage IV CRC have survival less than half that of those with PS of 0 at presentation <span class="citation" data-cites="lavin1536">(<a href="#/section" role="doc-biblioref" onclick="">Lavin et al., 1980</a>)</span> <span class="citation" data-cites="kemeny786">(<a href="#/section" role="doc-biblioref" onclick="">Kemeny and Braun, 1983</a>)</span></p>
<p>ECOG2 patients receiving first-line chemotherapy for CRC had 12% 60-day morality <span class="citation" data-cites="sargent1948">(<a href="#/section" role="doc-biblioref" onclick="">Sargent et al., 2009</a>)</span></p>
<p>Kohorana Score for CRC early death: (primary site, baseline hemoglobin, leukocyte and platelet counts, BMI) <span class="citation" data-cites="khorana4902">(<a href="#/section" role="doc-biblioref" onclick="">Khorana et al., 2008</a>)</span></p>
<p>Stage IV CRC prognostic model: [chibaudel1228] = f(performance status, LDH,number of metastatic sites). Serum LDH most prognostic factor, followed by PS</p>
<p>Kohne model: PS, WBC, ALP, number of metastatic sites <span class="citation" data-cites="kohne308">(<a href="#/section" role="doc-biblioref" onclick="">Köhne et al., 2002</a>)</span></p>
</section>
<h3 id="adjuvant-5fu-in-colon-cancer">Adjuvant 5FU in Colon cancer</h3>
<p>Adjuvant 5FU appears beneficial in the elderly Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG, Shepherd LE, Seitz JF, Francini G. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001;345:1091–1097</p>
<p>McCleary - ACCENT group analysis</p>
<h3 id="adjuvant-oxaliplatin-in-colon-cancer">Adjuvant Oxaliplatin in Colon cancer</h3>
<p>Addition of oxaliplatin to 5FU results in survival benefit for younger patients but may not be of benefit to elderly patients</p></section>
<section id="resources" class="title-slide slide level1 center">
<h1>Resources</h1>
<p>Dalane Kitzman - https://www.wakehealth.edu/providers/k/dalane-w-kitzman dkitzman@wakehealth.edu</p>
</section>

<section id="bmi-and-survival-in-stage-iv-cancer" class="title-slide slide level1 center">
<h1>BMI and survival in stage IV cancer</h1>
<p>Low BMI may be associated with high cancer-specific mortality (Renfro LA, Loupakis F, Adams RA. et al.&nbsp;Body mass index is prognostic in metastatic colorectal cancer: Pooled analysis of patients from first-line clinical trials in the ARCAD database. J Clin Oncol. 2016;34(2):144–150. 10.1200/JCO.2015.61.6441) High BMI may be an indicator of co-morbidities and may be associated with high non-cancer mortality ( Lee J, Meyerhardt JA, Giovannucci E, Jeon JY.. Association between body mass index and prognosis of colorectal cancer: A meta-analysis of prospective cohort studies. PLoS One. 2015;10:e0120706.) Visceral adiposity is associated with higher mortality in patients undergoing adjuvant chemotherapy (Lee CS, Murphy DJ, McMahon C, et al.&nbsp;Visceral adiposity is a risk factor for poor prognosis in colorectal cancer patients receiving adjuvant chemotherapy. J Gastrointest Cancer. 2015;46(3):243–250. 10.1007/s12029-015-9709-0)</p>
</section>

<section>
<section id="performance-status-and-chemo" class="title-slide slide level1 center">
<h1>Performance status and chemo</h1>
<p>Clinical trials typically enroll less than 10% of patients with PS of 2</p>
<p>ECOG may be less accurate in the low end of the scale <span class="citation" data-cites="verger1328">(<a href="#/section" role="doc-biblioref" onclick=""><strong>verger1328?</strong></a>)</span></p>
<p>Low inter-observer agreement (J. Myers, K. Gardiner, K. Harris et al., “Evaluating correlation and interrater reliability for four performance scales in the palliative care setting,” Journal of Pain and Symptom Management, vol.&nbsp;39, no. 2, pp.&nbsp;250–258, 2010.)</p>
<p>Poor inter-observer agreement of ECOG, with oncolgist and nurses recording higher values than patients (M. Ando, Y. Ando, Y. Hasegawa et al., “Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer,” British Journal of Cancer, vol.&nbsp;85, no. 11, pp.&nbsp;1634–1639, 2001)</p>
<p>Interobserver agreement between patient and oncologist 50% in lung cancer (S. P. Blagden, S. C. Charman, L. D. Sharples, L. R. A. Magee, and D. Gilligan, “Performance status score: do patients and their oncologists agree?” British Journal of Cancer, vol.&nbsp;89, no. 6, pp.&nbsp;1022–1027, 2003.)</p>
<p>M.M. Oken, R.H. Creech, D.C. Tormey, et al.&nbsp;Toxicity and response criteria of the eastern cooperative oncology group Am. J. Clin. Oncol., 5 (1982), pp.&nbsp;649-655</p>
<p>R. Chow, N. Chiu, E. Bruera, et al.&nbsp;Inter-rater reliability in performance status assessment among health care professionals: a systematic review Ann. Palliat. Med., 5 (2016), pp.&nbsp;83-92</p>
<p>All-cause mortality risk prediction in geriatric oncology <span class="citation" data-cites="perez-de-acha1377">(<a href="#/section" role="doc-biblioref" onclick="">Perez-de-Acha et al., 2022</a>)</span> Predicting life expectancy in older adults with cancer <span class="citation" data-cites="verduzco-aguirre68">(<a href="#/section" role="doc-biblioref" onclick="">Verduzco-Aguirre et al., 2019</a>)</span></p>
<p>Functional vs chronological age<span class="citation" data-cites="soto-perez-de-celise305">(<a href="#/section" role="doc-biblioref" onclick="">Soto-Perez-de-Celis et al., 2018</a>)</span></p>
</section>
<section id="undertreatment-of-elderly" class="slide level2">
<h2>Undertreatment of Elderly</h2>
<p>Surgery for colorectal cancer in elderly patients: a systematic review. Colorectal Cancer Collaborative Group. Lancet. 2000;356:968–974</p>
<p>Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93:850–857</p>
<p>Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20:1192–1202.</p>
<p>Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med. 2002;136:349–357</p>
<p>Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005;294:2703–2711.</p>
<p>110 CRC patients over age 75: only 6/23 received adjuvant chemotherapy. Out of 18 patients with stage IV disease, only 3 received palliative chemotherapy. Aparicio T, Navazesh A, Boutron I, Bouarioua N, Chosidow D, Mion M, Choudat L, Sobhani I, Mentré F, Soulé JC. Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment. Crit Rev Oncol Hematol. 2009;71:249–257</p>
<p>Adjuvant chemotherapy for stage III colon cancer appears to be efficacious in the elderly: Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol. 2002;20:3992–3998</p>
<p>Age and oncologist decisions <span class="citation" data-cites="foster584">(<a href="#/section" role="doc-biblioref" onclick="">Foster et al., 2010</a>)</span></p>
<p>Age and comorbidity affect recommendations for chemotherapy in stage III colon cancer - more variability of recommendation for older patients<span class="citation" data-cites="keating2532">(<a href="#/section" role="doc-biblioref" onclick="">Keating et al., 2008</a>)</span></p>
</section></section>
<section id="age-and-receipt-of-chemotherapy" class="title-slide slide level1 center">
<h1>Age and receipt of chemotherapy</h1>
<p>H. K. Sanoff, W. R. Carpenter, T. Sturmer et al.&nbsp;et al., “Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years,” Journal of Clinical Oncology, vol.&nbsp;30, no. 21, pp.&nbsp;2624–2634, 2012 D. Schrag, L. D. Cramer, P. B. Bach, and C. B. Begg, “Age and adjuvant chemotherapy use after surgery for stage III colon cancer,” Journal of the National Cancer Institute, vol.&nbsp;93, no. 11, pp.&nbsp;850–857, 2001.</p>
<p>Older patients do derive benefit from chemotherapy H. B. Muss, S. Woolf, D. Berry et al., “Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer,” The Journal of the American Medical Association, vol.&nbsp;293, no. 9, pp.&nbsp;1073–1081, 2005.</p>
<p>Older adults &gt;70 are less likely to be enrolled in 2nd line trials for</p>
</section>

<section id="platelet-neutrophil-leukocytes" class="title-slide slide level1 center">
<h1>Platelet Neutrophil Leukocytes</h1>
<p><span class="citation" data-cites="mercier478">(<a href="#/section" role="doc-biblioref" onclick="">Mercier and Voutsadakis, 2018</a>)</span></p>
<p>Tan D, Fu Y, Su Q, et al.&nbsp;Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2016;95:e3837.</p>
<p>Li MX, Liu XM, Zhang XF, et al.&nbsp;Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Int J Cancer 2014;134:2403-13.</p>
</section>

<section id="immunotherapy-in-frail-patients" class="title-slide slide level1 center">
<h1>Immunotherapy in Frail patients</h1>
<p>Creighton: <span class="citation" data-cites="krishnane175">(<a href="#/section" role="doc-biblioref" onclick="">Krishnan et al., 2022</a>)</span> 257 patients with advanced solid tumor receiving immune checkpoint inhibitors. 182 were ECOG 0-1 and 75 were ECOG &gt;=2. Median overall survival was 12.6 months for the ECOG PS 0-1 group compared with 3.1 months for the ECOG PS ≥ 2 group (P &lt; .001). The overall response rate for patients with ECOG PS 0-1 was 23% compared with 8% for those with poor PS (P = .005). Patients with poor PS treated with ICI had similar hospice referral rates (67% for ECOG PS ≥ 2 v 61.9% for ECOG PS 0-1, P = .50) but were more likely to have in-hospital death as compared with the good PS group (28.6% v 15.1%, P = .035).</p>
<p>India: <span class="citation" data-cites="kapoore25115">(<a href="#/section" role="doc-biblioref" onclick="">Kapoor et al., 2021</a>)</span> 155 patients receiving ICIs. ECOG 0-1 had median survival 9.1 months vs 2.9months in ECOG 2-4. Median OS for ECOG2 was 3.7months vs 1.8 months with ECOG 3-4</p>
<p>Meta-analysis of IC trials: No difference in benefit for ECOG 0 vs ECOG &gt;=1 <span class="citation" data-cites="yange2012534">(<a href="#/section" role="doc-biblioref" onclick="">Yang et al., 2020</a>)</span></p>
<p>Melanoma PS2-3 treated with ICI had median survival of 18 months vs 19.5 months for ECOG 0-1 <span class="citation" data-cites="wong385">(<a href="#/section" role="doc-biblioref" onclick="">Wong et al., 2017</a>)</span></p>
<p>Lung cancer with ECOG 2+ had worse prognosis than ECOG 0-1 in NSCLC treated with pembro <span class="citation" data-cites="sehgale2037120">(<a href="#/section" role="doc-biblioref" onclick=""><strong>sehgale2037120?</strong></a>)</span></p>
<p>NSCLC treated with ICI: shorter survival in ECOG 2+ compared with PS 0-1 <span class="citation" data-cites="petrillo2288">(<a href="#/section" role="doc-biblioref" onclick="">Petrillo et al., 2020</a>)</span></p>
<p>NSCLC meta-analysis of ECOG 2: <span class="citation" data-cites="tomasik97">(<a href="#/section" role="doc-biblioref" onclick="">Tomasik et al., 2021</a>)</span> Patients with impaired PS are twice as likely to achieve a response compared with ECOG 0-1</p>
<p>France <span class="citation" data-cites="facchinetti155">(<a href="#/section" role="doc-biblioref" onclick="">Facchinetti et al., 2020</a>)</span> 153 patients ECOG 2. Patients who were ECOG 2 due to comorbidities (n=41) had much better prognosis (median survival 11.8 vs 2.8 months) than those ECOG 2 due to disease burden(n=112)</p>
<p>Checkpoint inhibitor dose in the last 30 days of life associated with poor PS and dying in hospital <span class="citation" data-cites="bloome849">(<a href="#/section" role="doc-biblioref" onclick="">Bloom et al., 2022</a>)</span></p>
<p>Risk-adjusting Toxicity of chemotherapy</p>
<ol start="11" type="1">
<li>Hurria A, Togawa K, Mohile SG, et al.&nbsp;Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study. J Clin Oncol. 2011;29:3457–3465.</li>
</ol>
</section>

<section id="reporting" class="title-slide slide level1 center">
<h1>Reporting</h1>
<p>Benchimol EI, Smeeth L, Guttmann A, et al.&nbsp;The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. https://doi.org/10.1371/journal.pmed.1001885 . - DOI - PubMed - PMC</p>
</section>

<section id="palliative-care-consultations" class="title-slide slide level1 center">
<h1>Palliative Care consultations</h1>
<p>VA System: <span class="citation" data-cites="sullivan1702">(<a href="#/section" role="doc-biblioref" onclick="">Sullivan et al., 2019</a>)</span> Lung Cancer - palliative care consultation 31-365 days after dx led to increased survival</p>
</section>

<section id="enteral-nutrition-in-cancer-patients" class="title-slide slide level1 center">
<h1>Enteral nutrition in cancer patients</h1>
<p>In 347 stage IV gastric cancer patients at high nutrition risk and receiving palliative CT, nutritional support was associated with a survival benefit 39.Qiu M, ZhouYX, Jin Y, Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy. Support Care Cancer. 2015: 23; 1933. -9 Esophageal cancer patients RCT enteral therapy vs oral nutrition <span class="citation" data-cites="lyu839516">(<a href="#/section" role="doc-biblioref" onclick="">Lyu et al., 2022</a>)</span></p>
</section>

<section id="section" class="title-slide slide level1 smaller scrollable">
<h1></h1>


<div id="refs" class="references csl-bib-body hanging-indent" data-entry-spacing="0" role="list">
<div id="ref-bloome849" class="csl-entry" role="listitem">
Bloom, M.D., Saker, H., Glisch, C., Ramnaraign, B., George, T.J., Markham, M.J., Kelkar, A.H., 2022. Administration of <span>Immune</span> <span>Checkpoint</span> <span>Inhibitors</span> <span>Near</span> the <span>End</span> of <span>Life</span>. JCO oncology practice 18, e849–e856. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/35254868">35254868</a>
</div>
<div id="ref-chan147" class="csl-entry" role="listitem">
Chan, M., Hugh-Yeun, K., Gresham, G., Speers, C.H., Kennecke, H.F., Cheung, W.Y., 2017. Population-<span>Based</span> <span>Patterns</span> and <span>Factors</span> <span>Associated</span> <span>With</span> <span>Underuse</span> of <span>Palliative</span> <span>Systemic</span> <span>Therapy</span> in <span>Elderly</span> <span>Patients</span> <span>With</span> <span>Metastatic</span> <span>Colon</span> <span>Cancer</span>. Clinical Colorectal Cancer 16, 147–153. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/27670894">27670894</a>
</div>
<div id="ref-chen3395" class="csl-entry" role="listitem">
Chen, F., Wang, F., Bailey, C.E., Murff, H.J., Berlin, J.D., Shu, X.-O., Zheng, W., 2020. Evaluation of determinants for age disparities in the survival improvement of colon cancer: Results from a cohort of more than 486,000 patients in the <span>United</span> <span>States</span>. American Journal of Cancer Research 10, 3395–3405. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/33163278">33163278</a>
</div>
<div id="ref-facchinetti155" class="csl-entry" role="listitem">
Facchinetti, F., Mazzaschi, G., Barbieri, F., Passiglia, F., Mazzoni, F., Berardi, R., Proto, C., Cecere, F.L., Pilotto, S., Scotti, V., Rossi, S., Del Conte, A., Vita, E., Bennati, C., Ardizzoni, A., Cerea, G., Migliorino, M.R., Sala, E., Camerini, A., Bearz, A., De Carlo, E., Zanelli, F., Guaitoli, G., Garassino, M.C., Ciccone, L.P., Sartori, G., Toschi, L., Dall’Olio, F.G., Landi, L., Pizzutilo, E.G., Bartoli, G., Baldessari, C., Novello, S., Bria, E., Cortinovis, D.L., Rossi, G., Rossi, A., Banna, G.L., Camisa, R., Di Maio, M., Tiseo, M., 2020. First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. European Journal of Cancer (Oxford, England: 1990) 130, 155–167. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/32220780">32220780</a>
</div>
<div id="ref-foster584" class="csl-entry" role="listitem">
Foster, J.A., Salinas, G.D., Mansell, D., Williamson, J.C., Casebeer, L.L., 2010. How does older age influence oncologists’ cancer management? The Oncologist 15, 584–592. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/20495217">20495217</a>
</div>
<div id="ref-hurria3826" class="csl-entry" role="listitem">
Hurria, A., Levit, L.A., Dale, W., Mohile, S.G., Muss, H.B., Fehrenbacher, L., Magnuson, A., Lichtman, S.M., Bruinooge, S.S., Soto-Perez-de-Celis, E., Tew, W.P., Postow, M.A., Cohen, H.J., American Society of Clinical Oncology, 2015. Improving the <span>Evidence</span> <span>Base</span> for <span>Treating</span> <span>Older</span> <span>Adults</span> <span>With</span> <span>Cancer</span>: <span>American</span> <span>Society</span> of <span>Clinical</span> <span>Oncology</span> <span>Statement</span>. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 33, 3826–3833. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/26195697">26195697</a>
</div>
<div id="ref-kapoore25115" class="csl-entry" role="listitem">
Kapoor, A., Noronha, V., Patil, V.M., Menon, N., Joshi, A., Abraham, G., Prabhash, K., 2021. Immune checkpoint inhibitors in patients with solid tumors and poor performance status: <span>A</span> prospective data from the real-world settings. Medicine 100, e25115. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/33787593">33787593</a>
</div>
<div id="ref-keating2532" class="csl-entry" role="listitem">
Keating, N.L., Landrum, M.B., Klabunde, C.N., Fletcher, R.H., Rogers, S.O., Doucette, W.R., Tisnado, D., Clauser, S., Kahn, K.L., 2008. Adjuvant chemotherapy for stage <span>III</span> colon cancer: Do physicians agree about the importance of patient age and comorbidity? Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26, 2532–2537. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/18487570">18487570</a>
</div>
<div id="ref-kemeny786" class="csl-entry" role="listitem">
Kemeny, N., Braun, D.W., 1983. Prognostic factors in advanced colorectal carcinoma. <span>Importance</span> of lactic dehydrogenase level, performance status, and white blood cell count. The American Journal of Medicine 74, 786–794. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/6837602">6837602</a>
</div>
<div id="ref-khorana4902" class="csl-entry" role="listitem">
Khorana, A.A., Kuderer, N.M., Culakova, E., Lyman, G.H., Francis, C.W., 2008. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111, 4902–4907. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/18216292">18216292</a>
</div>
<div id="ref-kohne308" class="csl-entry" role="listitem">
Köhne, C.H., Cunningham, D., Di Costanzo, F., Glimelius, B., Blijham, G., Aranda, E., Scheithauer, W., Rougier, P., Palmer, M., Wils, J., Baron, B., Pignatti, F., Schöffski, P., Micheel, S., Hecker, H., 2002. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: Results of a multivariate analysis of 3825 patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13, 308–317. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/11886010">11886010</a>
</div>
<div id="ref-krishnane175" class="csl-entry" role="listitem">
Krishnan, M., Kasinath, P., High, R., Yu, F., Teply, B.A., 2022. Impact of <span>Performance</span> <span>Status</span> on <span>Response</span> and <span>Survival</span> <span>Among</span> <span>Patients</span> <span>Receiving</span> <span>Checkpoint</span> <span>Inhibitors</span> for <span>Advanced</span> <span>Solid</span> <span>Tumors</span>. JCO oncology practice 18, e175–e182. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/34351819">34351819</a>
</div>
<div id="ref-lavin1536" class="csl-entry" role="listitem">
Lavin, P., Mittelman, A., Douglass, H., Engstrom, P., Klaassen, D., 1980. Survival and response to chemotherapy for advanced colorectal adenocarcinoma: An <span>Eastern</span> <span>Cooperative</span> <span>Oncology</span> <span>Group</span> report. Cancer 46, 1536–1543. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/6998557">6998557</a>
</div>
<div id="ref-lyu839516" class="csl-entry" role="listitem">
Lyu, J., Shi, A., Li, T., Li, J., Zhao, R., Zhu, S., Wang, J., Xing, L., Yang, D., Xie, C., Shen, L., Zhang, H., Zhu, G., Wang, J., Pan, W., Li, F., Lang, J., Shi, H., 2022. Effects of <span>Enteral</span> <span>Nutrition</span> on <span>Patients</span> <span>With</span> <span>Oesophageal</span> <span>Carcinoma</span> <span>Treated</span> <span>With</span> <span>Concurrent</span> <span>Chemoradiotherapy</span>: <span>A</span> <span>Prospective</span>, <span>Multicentre</span>, <span>Randomised</span>, <span>Controlled</span> <span>Study</span>. Frontiers in Oncology 12, 839516. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/35280748">35280748</a>
</div>
<div id="ref-mercier478" class="csl-entry" role="listitem">
Mercier, J., Voutsadakis, I.A., 2018. The platelets-neutrophils to lymphocytes ratio: A new prognostic marker in metastatic colorectal cancer. Journal of Gastrointestinal Oncology 9, 478–486. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/29998013">29998013</a>
</div>
<div id="ref-perez-de-acha1377" class="csl-entry" role="listitem">
Perez-de-Acha, A., Pilleron, S., Soto-Perez-de-Celis, E., 2022. All-<span>Cause</span> <span>Mortality</span> <span>Risk</span> <span>Prediction</span> in <span>Older</span> <span>Adults</span> with <span>Cancer</span>: <span>Practical</span> <span>Approaches</span> and <span>Limitations</span>. Current Oncology Reports 24, 1377–1385. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/35648341">35648341</a>
</div>
<div id="ref-petrillo2288" class="csl-entry" role="listitem">
Petrillo, L.A., El-Jawahri, A., Nipp, R.D., Lichtenstein, M.R.L., Durbin, S.M., Reynolds, K.L., Greer, J.A., Temel, J.S., Gainor, J.F., 2020. <a href="https://doi.org/10.1002/cncr.32782">Performance status and end-of-life care among adults with non–small cell lung cancer receiving immune checkpoint inhibitors</a>. Cancer 126, 2288–2295.
</div>
<div id="ref-rosati578" class="csl-entry" role="listitem">
Rosati, G., Cordio, S., Reggiardo, G., Aprile, G., Butera, A., Avallone, A., Tucci, A., Novello, G., Blanco, G., Caputo, G., Bilancia, D., Bordonaro, R., 2019. Oxaliplatin-<span>Based</span> <span>Chemotherapy</span> in <span>Patients</span> with <span>Metastatic</span> <span>Colorectal</span> <span>Cancer</span> <span>Aged</span> at <span>Least</span> 75 <span>Years</span>: <span>A</span> <span>Post</span>-<span>Hoc</span> <span>Subgroup</span> <span>Analysis</span> of <span>Three</span> <span>Phase</span> <span>II</span> <span>Trials</span>. Cancers 11, 578. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/31022922">31022922</a>
</div>
<div id="ref-sargent1948" class="csl-entry" role="listitem">
Sargent, D.J., Köhne, C.H., Sanoff, H.K., Bot, B.M., Seymour, M.T., Gramont, A. de, Porschen, R., Saltz, L.B., Rougier, P., Tournigand, C., Douillard, J.-Y., Stephens, R.J., Grothey, A., Goldberg, R.M., 2009. Pooled <span>Safety</span> and <span>Efficacy</span> <span>Analysis</span> <span>Examining</span> the <span>Effect</span> of <span>Performance</span> <span>Status</span> on <span>Outcomes</span> in <span>Nine</span> <span>First</span>-<span>Line</span> <span>Treatment</span> <span>Trials</span> <span>Using</span> <span>Individual</span> <span>Data</span> <span>From</span> <span>Patients</span> <span>With</span> <span>Metastatic</span> <span>Colorectal</span> <span>Cancer</span>. Journal of Clinical Oncology 27, 1948–1955. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/19255311">19255311</a>
</div>
<div id="ref-schnipper10" class="csl-entry" role="listitem">
Schnipper, L.E., Smith, T.J., Raghavan, D., Blayney, D.W., Ganz, P.A., Mulvey, T.M., Wollins, D.S., n.d. American <span>Society</span> of <span>Clinical</span> <span>Oncology</span> <span>Identifies</span> <span>Five</span> <span>Key</span> <span>Opportunities</span> to <span>Improve</span> <span>Care</span> and <span>Reduce</span> <span>Costs</span>: <span>The</span> <span>Top</span> <span>Five</span> <span>List</span> for <span>Oncology</span>. JOURNAL OF CLINICAL ONCOLOGY 10.
</div>
<div id="ref-simmonds531" class="csl-entry" role="listitem">
Simmonds, P.C., 2000. Palliative chemotherapy for advanced colorectal cancer: Systematic review and meta-analysis. <span>Colorectal</span> <span>Cancer</span> <span>Collaborative</span> <span>Group</span>. BMJ (Clinical research ed.) 321, 531–535. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/10968812">10968812</a>
</div>
<div id="ref-soto-perez-de-celise305" class="csl-entry" role="listitem">
Soto-Perez-de-Celis, E., Li, D., Yuan, Y., Lau, Y.M., Hurria, A., 2018. Functional versus chronological age: Geriatric assessments to guide decision making in older patients with cancer. The Lancet. Oncology 19, e305–e316. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/29893262">29893262</a>
</div>
<div id="ref-sullivan1702" class="csl-entry" role="listitem">
Sullivan, D.R., Chan, B., Lapidus, J.A., Ganzini, L., Hansen, L., Carney, P.A., Fromme, E.K., Marino, M., Golden, S.E., Vranas, K.C., Slatore, C.G., 2019. Association of <span>Early</span> <span>Palliative</span> <span>Care</span> <span>Use</span> <span>With</span> <span>Survival</span> and <span>Place</span> of <span>Death</span> <span>Among</span> <span>Patients</span> <span>With</span> <span>Advanced</span> <span>Lung</span> <span>Cancer</span> <span>Receiving</span> <span>Care</span> in the <span>Veterans</span> <span>Health</span> <span>Administration</span>. JAMA oncology 5, 1702–1709. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/31536133">31536133</a>
</div>
<div id="ref-tomasik97" class="csl-entry" role="listitem">
Tomasik, B., Bieńkowski, M., Braun, M., Popat, S., Dziadziuszko, R., 2021. Effectiveness and safety of immunotherapy in <span>NSCLC</span> patients with <span>ECOG</span> <span>PS</span> score ≥2 - <span>Systematic</span> review and meta-analysis. Lung Cancer (Amsterdam, Netherlands) 158, 97–106. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/34144405">34144405</a>
</div>
<div id="ref-verduzco-aguirre68" class="csl-entry" role="listitem">
Verduzco-Aguirre, H.C., Gomez-Moreno, C., Chavarri-Guerra, Y., Soto-Perez-de-Celis, E., 2019. Predicting <span>Life</span> <span>Expectancy</span> for <span>Older</span> <span>Adults</span> with <span>Cancer</span> in <span>Clinical</span> <span>Practice</span>: <span>Implications</span> for <span>Shared</span> <span>Decision</span>-making. Current Oncology Reports 21, 68. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/31240500">31240500</a>
</div>
<div id="ref-wong385" class="csl-entry" role="listitem">
Wong, A., Williams, M., Milne, D., Morris, K., Lau, P., Spruyt, O., Fullerton, S., McArthur, G., 2017. Clinical and palliative care outcomes for patients of poor performance status treated with antiprogrammed death-1 monoclonal antibodies for advanced melanoma. Asia-Pacific Journal of Clinical Oncology 13, 385–390. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/28661584">28661584</a>
</div>
<div id="ref-yange2012534" class="csl-entry" role="listitem">
Yang, F., Markovic, S.N., Molina, J.R., Halfdanarson, T.R., Pagliaro, L.C., Chintakuntlawar, A.V., Li, R., Wei, J., Wang, L., Liu, B., Nowakowski, G.S., Wang, M.L., Wang, Y., 2020. Association of <span>Sex</span>, <span>Age</span>, and <span>Eastern</span> <span>Cooperative</span> <span>Oncology</span> <span>Group</span> <span>Performance</span> <span>Status</span> <span>With</span> <span>Survival</span> <span>Benefit</span> of <span>Cancer</span> <span>Immunotherapy</span> in <span>Randomized</span> <span>Clinical</span> <span>Trials</span>: <span>A</span> <span>Systematic</span> <span>Review</span> and <span>Meta</span>-analysis. JAMA network open 3, e2012534. https://vb3lk7eb4t.search.serialssolutions.com/?id=<a href="https://www.ncbi.nlm.nih.gov/pubmed/32766800">32766800</a>
</div>
</div>
</section>
    </div>
  <div class="quarto-auto-generated-content" style="display: none;">
<div class="footer footer-default">

</div>
</div></div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="site_libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="site_libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="site_libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="site_libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="site_libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="site_libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="site_libs/revealjs/plugin/notes/notes.js"></script>
  <script src="site_libs/revealjs/plugin/search/search.js"></script>
  <script src="site_libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="site_libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'jumpToSlide': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.toggleScrollView(event)\"><kbd>r</kbd> Scroll View Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"5\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: false,

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.9/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
      window.document.addEventListener("DOMContentLoaded", function (event) {
        const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
        tabsets.forEach(function(tabset) {
          const tabby = new Tabby('#' + tabset.id);
        });
        const isCodeAnnotation = (el) => {
          for (const clz of el.classList) {
            if (clz.startsWith('code-annotation-')) {                     
              return true;
            }
          }
          return false;
        }
        const onCopySuccess = function(e) {
          // button target
          const button = e.trigger;
          // don't keep focus
          button.blur();
          // flash "checked"
          button.classList.add('code-copy-button-checked');
          var currentTitle = button.getAttribute("title");
          button.setAttribute("title", "Copied!");
          let tooltip;
          if (window.bootstrap) {
            button.setAttribute("data-bs-toggle", "tooltip");
            button.setAttribute("data-bs-placement", "left");
            button.setAttribute("data-bs-title", "Copied!");
            tooltip = new bootstrap.Tooltip(button, 
              { trigger: "manual", 
                customClass: "code-copy-button-tooltip",
                offset: [0, -8]});
            tooltip.show();    
          }
          setTimeout(function() {
            if (tooltip) {
              tooltip.hide();
              button.removeAttribute("data-bs-title");
              button.removeAttribute("data-bs-toggle");
              button.removeAttribute("data-bs-placement");
            }
            button.setAttribute("title", currentTitle);
            button.classList.remove('code-copy-button-checked');
          }, 1000);
          // clear code selection
          e.clearSelection();
        }
        const getTextToCopy = function(trigger) {
            const codeEl = trigger.previousElementSibling.cloneNode(true);
            for (const childEl of codeEl.children) {
              if (isCodeAnnotation(childEl)) {
                childEl.remove();
              }
            }
            return codeEl.innerText;
        }
        const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
          text: getTextToCopy
        });
        clipboard.on('success', onCopySuccess);
        if (window.document.getElementById('quarto-embedded-source-code-modal')) {
          const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
            text: getTextToCopy,
            container: window.document.getElementById('quarto-embedded-source-code-modal')
          });
          clipboardModal.on('success', onCopySuccess);
        }
          var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
          var mailtoRegex = new RegExp(/^mailto:/);
            var filterRegex = new RegExp("https:\/\/gisurgonc\.github\.io\/talks\/");
          var isInternal = (href) => {
              return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
          }
          // Inspect non-navigation links and adorn them if external
         var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
          for (var i=0; i<links.length; i++) {
            const link = links[i];
            if (!isInternal(link.href)) {
              // undo the damage that might have been done by quarto-nav.js in the case of
              // links that we want to consider external
              if (link.dataset.originalHref !== undefined) {
                link.href = link.dataset.originalHref;
              }
            }
          }
        function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
          const config = {
            allowHTML: true,
            maxWidth: 500,
            delay: 100,
            arrow: false,
            appendTo: function(el) {
                return el.closest('section.slide') || el.parentElement;
            },
            interactive: true,
            interactiveBorder: 10,
            theme: 'light-border',
            placement: 'bottom-start',
          };
          if (contentFn) {
            config.content = contentFn;
          }
          if (onTriggerFn) {
            config.onTrigger = onTriggerFn;
          }
          if (onUntriggerFn) {
            config.onUntrigger = onUntriggerFn;
          }
            config['offset'] = [0,0];
            config['maxWidth'] = 700;
          window.tippy(el, config); 
        }
        const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
        for (var i=0; i<noterefs.length; i++) {
          const ref = noterefs[i];
          tippyHover(ref, function() {
            // use id or data attribute instead here
            let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
            try { href = new URL(href).hash; } catch {}
            const id = href.replace(/^#\/?/, "");
            const note = window.document.getElementById(id);
            if (note) {
              return note.innerHTML;
            } else {
              return "";
            }
          });
        }
        const findCites = (el) => {
          const parentEl = el.parentElement;
          if (parentEl) {
            const cites = parentEl.dataset.cites;
            if (cites) {
              return {
                el,
                cites: cites.split(' ')
              };
            } else {
              return findCites(el.parentElement)
            }
          } else {
            return undefined;
          }
        };
        var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
        for (var i=0; i<bibliorefs.length; i++) {
          const ref = bibliorefs[i];
          const citeInfo = findCites(ref);
          if (citeInfo) {
            tippyHover(citeInfo.el, function() {
              var popup = window.document.createElement('div');
              citeInfo.cites.forEach(function(cite) {
                var citeDiv = window.document.createElement('div');
                citeDiv.classList.add('hanging-indent');
                citeDiv.classList.add('csl-entry');
                var biblioDiv = window.document.getElementById('ref-' + cite);
                if (biblioDiv) {
                  citeDiv.innerHTML = biblioDiv.innerHTML;
                }
                popup.appendChild(citeDiv);
              });
              return popup.innerHTML;
            });
          }
        }
      });
      </script>
    

</body></html>